More than 100 Zofran birth defects lawsuits have been compiled into a multi-district litigation (MDL) in Massachusetts. U.S. District Judge Dennis Saylor appointed three veteran MDL attorneys as co-lead counsel for the lawsuits, which could play a large role in determining the future of the Zofran lawsuits.
The lawsuits are being filed by the parents of children who were born with birth defects after being exposed to Zofran while in the womb. Many children were born with defects such as cleft palate, cleft lip, heart defects and other congenital birth defects. Studies have shown a potentially increased risk of birth defects associated with using Zofran during pregnancy.
Zofran is an anti-nausea drug that was approved by the U.S. Food and Drug Administration (FDA) for treatment in post-surgery and cancer patients. However, many doctors have begun prescribing Zofran to treat morning sickness in pregnant women, despite the drug not being approved for the use by the FDA.
The pharmaceutical industry has a sordid history with morning sickness drugs. In the 1950s, thousands of children in Germany and other countries were maimed and born without limbs after women were given thalidomide to treat sickness. That drug was blocked from entering the U.S. thanks to the FDA.